Metabolic Signature of Type 2 Diabetes, Insulin Resistance, and Obesity Triad
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 44
Special Issue Editor
2. Clinic of Diabetes, Nutrition and Metabolic Diseases, Emergency County Hospital, 200642 Craiova, Romania
Interests: metabolic diseases epidemiology; biochemical and molecular biomarkers of obesity and diabetes; pancreatic neuroendocrine tumors; bariatric surgery; insulin resistance; obesity phenotypes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metabolic diseases represent a major challenge and a public health problem worldwide, obesity and type 2 diabetes being the most prevalent metabolic disorders causing serious short- and long-term adverse health outcomes and comorbidities.
In recent years, two atypical phenotypes of obesity have been described - metabolically healthy obesity, which is not associated with insulin resistance or cardiometabolic profile characteristic of obesity, and metabolically unhealthy normal weight, characterized by the presence of insulin resistance in normal weight individuals.
However, despite the high prevalence of obesity, atypical obesity phenotypes, and type 2 diabetes, the exact etiology is poorly understood, and there is still debate regarding the molecular pathways and metabolic signature, the diagnostic threshold to apply for identification of the cardiometabolic phenotypes of obesity, and the optimal therapeutic strategies.
In recent years, new biochemical and molecular biomarkers, including genetic variants, DNA methylation, specific miRNAs, microbiota, microbial metabolites, mitochondrial dysfunction, adipocytokines, metabolomic profiles, the entero-insular axis, and the neuro-adipocyte axis, have garnered significant interest in the diagnosis and prognosis of the metabolic triad.
This Special Issue will be dedicated to the impact of microbiota, genetic, epigenetic and neuro-endocrino-metabolic factors on pathogenesis and diagnosis of the obesity, insulin resistance and type 2 diabetes triad, welcoming all those studies that will help to identify future diagnostic approaches for the detection of obesity cardiometabolic phenotypes and evaluate personalized and effective nutrition and pharmacological strategies for prevention and management of metabolic triad.
Dr. Simona Georgiana Popa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiometabolic phenotypes of obesity
- metabolomic profiles
- microbiota
- entero-insular axis
- adipocytokines
- precision therapy
- insulin resistance
- type 2 diabetes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
